|
Is there a guidance document for ATMPs during process changes or manufacturing scale-up?
|
|
1
|
20
|
March 19, 2025
|
|
Vaccines & the EU HTA Regulation: Why, What and How?
|
|
0
|
5
|
March 19, 2025
|
|
Platform Trials
|
|
0
|
8
|
March 14, 2025
|
|
Is there a format or guidance document for writing a product development plan and IMPD specifically for ATMPs
|
|
3
|
26
|
March 14, 2025
|
|
FAST ATMP webinar part 2 - Non-clinical development, clinical development, Regulation and legislation
|
|
1
|
32
|
March 14, 2025
|
|
DARE-NL Annual Consortium Meeting
|
|
0
|
3
|
March 14, 2025
|
|
Research Roadmap AmsterdamUMC useful for academic developers (not only in Amsterdam)
|
|
0
|
6
|
March 13, 2025
|
|
Proefdiervrij Event 2025: Unlocking Potential - From innovation to implementation: shaping the future of animal-free science
|
|
0
|
4
|
March 13, 2025
|
|
P3Dx Symposium – De Toekomst van Testen (in Dutch)
|
|
0
|
3
|
March 13, 2025
|
|
7 recommendations to to improve reproducibility, comparability, and visibility in preclinical TRT research
|
|
0
|
5
|
March 13, 2025
|
|
Online information about Gene Therapy for monogenic diseases - for patients
|
|
0
|
11
|
March 11, 2025
|
|
How can the lack of formal documentation in patient involvement activities be addressed?
|
|
4
|
67
|
March 11, 2025
|
|
FAST ATMP Webinar part 1 - Patient participation, classification of ATMPs, product development
|
|
1
|
89
|
March 10, 2025
|
|
Non-animal methods in infection and immunity, neuroscience, oncology en cardiovascular science
|
|
0
|
5
|
March 5, 2025
|
|
Biotech Booster event
|
|
0
|
7
|
March 4, 2025
|
|
Pharmacy preparation vs hospital exemptions – is there a difference?
|
|
1
|
34
|
March 3, 2025
|
|
ISPOR Europe 2025
|
|
0
|
6
|
February 28, 2025
|
|
What are the differences in regulatory pathways for obtaining approval for repurposed drugs in the EU, UK and US?
|
|
0
|
5
|
February 25, 2025
|
|
For which infectious diseases are there Controlled Human Infection Models (CHIMs) available?
|
|
0
|
5
|
February 25, 2025
|
|
Webinar: “Clinical Trials in Focus: Innovations and Patient Perspectives in Rare Diseases”
|
|
0
|
7
|
February 24, 2025
|
|
CBG Science Day 2025 - Platform Technologies: opportunities and challenges
|
|
1
|
25
|
February 24, 2025
|
|
Pay for performance in the Netherlands, are guidelines available?
|
|
4
|
50
|
February 21, 2025
|
|
Reimbursement of a new therapy
|
|
2
|
19
|
February 21, 2025
|
|
CBG collegedag - De toekomst van medicijnbeoordeling: de veranderende rol van data en patiënt
|
|
0
|
11
|
February 19, 2025
|
|
Innovation Mission Sweden: Quantum Technology
|
|
0
|
5
|
February 20, 2025
|
|
FAST ATMP webinar part 3 - Market authorization, hospital exemptions, reimbursement
|
|
0
|
16
|
January 8, 2025
|
|
When to use Human Challenge Models and Controlled Human Infection Models
|
|
0
|
5
|
February 19, 2025
|
|
Patient involvement in therapy development
|
|
1
|
15
|
February 19, 2025
|
|
N-of-1 therapy development
|
|
3
|
29
|
February 19, 2025
|
|
Is the drug that I want to prescribe reimbursed?
|
|
1
|
17
|
February 18, 2025
|